Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel in Advanced Cervical and Vaginal Cancer
NCT00002562Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Mar 1994
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of paclitaxel in Cervical Cancer (CC) and vaginal cancer, sponsored by GOG Foundation. Primary endpoints: Objective Response Rate, Duration of Objective Response and 3 more. Started Mar 1994; status: completed.
02
Drugs
paclitaxel
03
Conditions
Cervical Cancer (CC)vaginal cancer
Beyond the preview
Go deeper on NCT00002562.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002562.